We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





AIRS Medical Showcases Award-Winning MRI Enhancement AI Solution at RSNA 2022

By MedImaging International staff writers
Posted on 26 Nov 2022
Print article
Image: AIRS is presenting the future of MRI imaging at RSNA 2022 (Photo courtesy of AIRS)
Image: AIRS is presenting the future of MRI imaging at RSNA 2022 (Photo courtesy of AIRS)

AIRS Medical, Inc. (Seoul, South Korea) is participating in the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2022), the world's leading annual imaging forum, at McCormick Place in Chicago held from November 27 to December 1, 2022.

At its RSNA booth, AIRS is showcasing SwiftMR, an FDA 510(k)-cleared AI Imaging solution that enhances MR images acquired under various conditions, contributing to better image quality and patient experience. SwiftMR utilizes conventional MR imaging techniques such as parallel Imaging and compressed sensing, combined with its award-winning deep learning technology. SwiftMR enhances SNR and sharpness of the images, allowing radiologists to read with confidence and ease. SwiftMR was cleared by both the US FDA and the Korea Ministry of Food and Drug Safety (MFDS) in 2021. Since its official commercial launch in Korea in the fourth quarter of 2021, SwiftMR has been installed in more than 100 hospitals, for an average of 30,000 monthly MRI exams and a grand total of more than 280,000 MRI exams.

Along with booth demonstrations, a special presentation is being held by Roh-Eul Yoo, MD, Ph.D., from the Seoul National University Hospital. Dr. Yoo will be sharing her experience working with SwiftMR in various clinical scenarios, along with the results of recent research collaborations proving the power of SwiftMR in providing superior image quality. Due to its physical principles, MR exams inherently require long scan times, which not only present a negative healthcare experience to the patients, but also limit the productivity of healthcare providers. Image acquisition times could be reduced by various methods, but this mostly results in reduced diagnostic image quality. This balance between scan time and image quality has been the center of MR technology innovation for decades.

With the advent of deep learning, fast MRI also faces a new frontier, as obtaining better image quality with significantly less scan time has been made possible. However, developing a viable model for clinical deployment is hindered by a variety of reasons in different dimensions including wide range of contrast mechanisms, difficulties in defining the label and obtaining large-scale high-quality image data to enable the model training process. In this short talk, real-world experiences of utilizing SwiftMR in routine clinical practice and collaborative research will be shared.

Related Links:
AIRS Medical, Inc. 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
DRF DR & Remote Fluoroscopy Solution
CombiDiagnost R90
New
Ultra-Flat DR Detector
meX+1717SCC
NMUS & MSK Ultrasound
InVisus Pro

Print article
Radcal

Channels

MRI

view channel
Image: The new AI model efficiently reaches clinical-expert-level accuracy in complex medical scans (Photo courtesy of Leticia Ortiz/UCLA)

AI Model Achieves Clinical Expert Level Accuracy in Analyzing Complex MRIs and 3D Medical Scans

Artificial neural networks train by performing repeated calculations on large datasets that have been carefully examined and labeled by clinical experts. While standard 2D images display length and width,... Read more

Ultrasound

view channel
Image: Disease captured by the hand-held 3D photoacoustic scanner (Photo courtesy of Dr. Nam Huynh)

Medical Imaging Breakthrough to Revolutionize Cancer and Arthritis Diagnosis

Photoacoustic tomography (PAT) imaging uses laser-generated ultrasound waves to detect subtle changes in small veins and arteries, typically less than a millimeter in size and up to 15mm deep in human tissues.... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

General/Advanced Imaging

view channel
Image: A kidney showing positive [89Zr]Zr-girentuximab PET and histologically confirmed clear-cell renal cell carcinoma (Photo courtesy of Dr. Brian Shuch/UCLA Health)

Non-Invasive Imaging Technique Accurately Detects Aggressive Kidney Cancer

Kidney cancers, known as renal cell carcinomas, account for 90% of solid kidney tumors, with over 81,000 new cases diagnosed annually in the United States. Among the various types, clear-cell renal cell... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.